REMEDi4ALL, an EU-funded research project, kicks off to drive forward the repurposing of medicines in Europe
Home News REMEDi4ALL, an EU-funded research project, kicks off to drive forward the repurposing of medicines in Europe

REMEDi4ALL, an EU-funded research project, kicks off to drive forward the repurposing of medicines in Europe

SEPTEMBER 14, 2022 BHH News
BHH member Teamit Research will lead together with EATRIS, the operational, communication and exploitation strategies to ensure the smooth implementation of the project and long-term impact. Identifying new therapeutic options for existing medicines (or drug repurposing) has the potential to significantly bring down the time and costs involved in drug development. This novel approach opens a window of opportunity in areas with high unmet medical needs -rare or neglected diseases, cancer, public health emergencies- but is still in an early development stage. To advance on this direction, the EU is funding the REMEDi4LL Consortium with 23 million euros in the next 5 years through the Horizon Europe (HE) programme with the objective of making patient-centric drug repurposing the new normal. This will have an impact not only on patients worldwide but will also contribute to the sustainability of health systems. During this period, the project will develop an innovative platform to support promising repurposing projects championed by patients. REMEDi4ALL has selected four medicine repurposing projects in different stages of development to demonstrate the viability of the newly created platform. Each project covers a different therapeutic area with high unmet medical needs– pancreatic cancer, COVID-19, rare diseases and ultra-rare diseases-. These projects will first be onboarded to ensure a patient-centric approach before testing all elements of the platform to optimise its tools and services. REMEDi4ALL will also build a global community to advance on key aspects -regulatory, policy, market access- for future proofing medicine repurposing. Teamit’s contribution to a unique combination of expertise Under the leadership of EATRIS, the European infrastructure for translational medicine, 24 organisations will combine their expertise in the fields of clinical and translational research, clinical operations, patient engagement and education, regulatory framework, funding, governance, Health Technology Assessment (HTA) or pricing and reimbursement to make cost-effective repurposed medicines more widely available. Teamit Research was heavily involved in the proposal stage and will now play a major role in operational, communication, dissemination, international networking and exploitation strategies to ensure the smooth implementation of the project and long-term impact. Eva Molero, Teamit’s CEO explains: “REMEDi4ALL will mark a turning point in how medicines are developed in Europe. It represents a unique opportunity to improve people’s health by enabling patients’ access to life-saving treatments in a cost-effective way. This vision, totally aligned with Teamit’s, inspires us enormously to give our best and achieve this important goal.”
June 12, 2024 BHH News
Siemens Healthineers and Barcelona Health Hub sign partnership to drive breakthrough innovations for equitable, quality healthcare
This partnership opens a collaboration line between both entities to advance towards a future where medical care and technological advancements help healthcare professionals deliver high-quality care, thus achieving the best possible outcomes for patients.
Read more
June 10, 2024 BHH News
Menarini and Barcelona Health Hub join forces to promote the incorporation of digital health innovation into the healthcare field
Open collaboration and co-creation are the pillars for generating innovation in healthcare. Technological and scientific advances can be significantly accelerated when collaborative environments are fostered.
Read more
June 06, 2024 BHH News
BHH Podcast - Mediktor
BHH member Mediktor joins in this episode with CEO Cristian Pascual.  Listen to Cristian share his journey in revolutionizing healthcare through AI-driven medical triage. 
Read more
June 05, 2024 BHH News
CHV-FHSC signs a strategic alliance with Barcelona Health Hub
This alliance is to carry out joint activities to share concerns and knowledge that lead to the development of new technology projects.
Read more
June 05, 2024 BHH News
BHH ON AIR with Vodafone Business at Revolució 4.0 at Catalunya Ràdio
If you’re looking for a quick catch-up about all things related to digital health, don’t miss BHH this weekend at Catalunya Ràdio!
Read more
May 29, 2024 BHH News
Teladoc Health joins Barcelona Health Hub to support its mission to advance innovation in digital health
Teladoc Health, the world's leading virtual care company, with revenues of 2.6 billion USD in 2023, joins Barcelona Health Hub. 
Read more
May 22, 2024 BHH News
Check out the state of Digital Health in Catalonia
This is your chance to dive deep into the state of digital health in Catalonia with this elaborated by ACCIÓ, in collaboration with Barcelona Health Hub.
Read more
May 09, 2024 BHH News
Explore the 'Sandbox of the System' at the Stage Hospital de la Santa Creu i Sant Pau
Explore the Hospital de la Santa Creu i Sant Pau Stage as the latest track of the Health Revolution Congress on May 16th!
Read more
May 09, 2024 BHH News
BHH ON AIR with Fundació Sant Pau at Revolució 4.0 at Catalunya Ràdio
If you’re looking for a quick catch-up about all things related to digital health, don’t miss BHH this weekend at Catalunya Ràdio!
Read more
May 03, 2024 BHH News
Stage Biocat: New Pathways for the Adoption of Healthcare Innovation in Catalonia
Discover the Biocat morning session as part of the Health Revolution Congress on May 16th.
Read more